|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1992-8-25
|
|
pubmed:abstractText |
To increase the hematologic tolerance of interferon-alpha (IFN alpha) and zidovudine combination therapy by the addition of granulocyte-macrophage colony-stimulating factor (GM-CSF), and to evaluate the safety, tolerance, and potential efficacy of the combination in patients with Kaposi's sarcoma and AIDS.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1344-51
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:1634925-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1634925-Adult,
pubmed-meshheading:1634925-Analysis of Variance,
pubmed-meshheading:1634925-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1634925-Drug Evaluation,
pubmed-meshheading:1634925-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:1634925-Humans,
pubmed-meshheading:1634925-Interferon-alpha,
pubmed-meshheading:1634925-Male,
pubmed-meshheading:1634925-Middle Aged,
pubmed-meshheading:1634925-Neutropenia,
pubmed-meshheading:1634925-Sarcoma, Kaposi,
pubmed-meshheading:1634925-Zidovudine
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
|
|
pubmed:affiliation |
Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
